Alumis Inc. Common Stock (ALMS) is a publicly traded Healthcare sector company. As of May 21, 2026, ALMS trades at $22.66 with a market cap of $2.70B and a P/E ratio of -12.17. ALMS moved +2.37% today. Year to date, ALMS is +165.22%; over the trailing twelve months it is +351.64%. Its 52-week range spans $2.76 to $30.60. Analyst consensus is strong buy with an average price target of $40.44. Rallies surfaces ALMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent ALMS insider activity includes AKKARAJU SRINIVAS bought 588.24K, Foresite Labs, LLC bought 117.65K, Foresite Labs, LLC bought 294.12K, Foresite Capital Management VI LLC bought 117.65K, and Foresite Capital Management VI LLC bought 294.12K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $22.66 |
| Market Cap | $2.70B |
| P/E Ratio | -12.17 |
| EPS | $-1.78 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.60 |
| 52-Week Low | $2.76 |
| Volume | 112 |
| Avg Volume | 0 |
| Revenue (TTM) | $8.40M |
| Net Income | $-237.41M |
| Gross Margin | 0.00% |
9 analysts cover ALMS: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.44.